tirzepatide safety concerns Frontiers Subcutaneously administered tirzepatide vs semaglutide

You get tracking by email

One way that semaglutide enhances metabolic efficiency is by reducing insulin resistance

GLP-1 induces the ileal brake phenomenon by inhibition of gastric emptying and intestinal transit time

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study

GLP-1 and GIP/GLP-1 receptor agonists for Type 2 diabetes GLP-1 and GIP/GLP-1 receptor agonists were originally FDA approved to treat Type 2 diabetes

Patients should contact their GP or diabetes care team if gastrointestinal symptoms are severe, persistent, or significantly impacting quality of life and nutritional intake